MET and neoplasm: It was hypothesized that the higher level of MET expression in HT29 tumor cells would facilitate LAV uptake through an ‘avidity-like’ effect, which would compensate for the reduced mAb affinity, while sparing TMDD via the majority (or enough) of the antigens in normal tissue sinks and thereby increase the therapeutic index.